Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost.
Moll M, Magrowski Ł, Mittlböck M, Heinzl H, Kirisits C, Ciepał J, Masri O, Heilemann G, Stando R, Krzysztofiak T, Depowska G, d'Amico A, Techmański T, Kozub A, Majewski W, Suwiński R, Wojcieszek P, Sadowski J, Widder J, Goldner G, Miszczyk M.
Moll M, et al. Among authors: ciepal j.
Strahlenther Onkol. 2025 Jan;201(1):11-19. doi: 10.1007/s00066-024-02245-3. Epub 2024 Jun 3.
Strahlenther Onkol. 2025.
PMID: 38829436
Free PMC article.